iRhythm Holdings, Inc. IRTC
Set alert
As of Nov 3, 12:35 PM ET
- YTD
- -28.71%
- 1 year
- -31.63%
- Open
- 125.96
- Prev close
- 126.17
- Mkt cap
- 4.18B
- Vol
- 95.60K
- Avg vol
- 567.91K
- EPS
- -0.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 124.50
- High
- 127.88
- Forward P/E
- 101.29
- Beta
- 1.47
- Short ratio
- 6.26
- Inst. own
- 107.82%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 115.04
- 200-d avg
- 122.38
- 1y target
- 171.33
5D chart
Signals (133)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 4:00 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 3:40 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 3:40 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 3:20 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 3:20 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 3:00 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 2:25 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 2:25 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 2:20 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 2:05 PM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 2:05 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 1:30 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 1:25 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 1:00 PM | 23 hours ago |
Newest 20 of 133.
News
5 days ago zacks.com
iRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?
IRHYTHM HLDGS (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 weeks ago defenseworld.net
Critical Review: TransMedics Group (NASDAQ:TMDX) & iRhythm Technologies (NASDAQ:IRTC)
TransMedics Group (NASDAQ: TMDX - Get Free Report) and iRhythm Technologies (NASDAQ: IRTC - Get Free Report) are both mid-cap healthcare companies, but which is the better investment? We will…
2 weeks ago benzinga.com
This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Analysts initiated coverage: ELAN Buy/$32, IRTC Overweight/$160, BAND Equal-Weight/$56, HRTG Market Perform, and URBN Buy/$100.
-
2 weeks ago benzinga.com
Piper Sandler Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160
Piper Sandler analyst Adam Maeder initiates coverage on iRhythm Holdings (NASDAQ:IRTC) with a Overweight rating and announces Price Target of $160.
2 weeks ago globenewswire.com
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026
SAN FRANCISCO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent…
2 weeks ago prnewswire.com
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
3 weeks ago globenewswire.com
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed
Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at iRhythm Holdings, Inc.
-
4 weeks ago benzinga.com
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $150
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $168 to $150.
4 weeks ago defenseworld.net
iRhythm (NASDAQ: IRTC) closes Vital Connect buy for $237.5 million
What happened On October 5, 2026, iRhythm Holdings, Inc. (NASDAQ: IRTC) said it completed its previously announced acquisition of Vital Connect, Inc. The buyer was iRhythm Technologies, Inc.,…
-
4 weeks ago benzinga.com
Needham Maintains Buy on iRhythm Holdings, Raises Price Target to $194
Needham analyst David Saxon maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $192 to $194.
4 weeks ago globenewswire.com
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
SAN FRANCISCO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC) today announced that it completed the previously announced acquisition of Vital Connect, Inc. ("VitalConnect"),…
-
1 month ago benzinga.com
iRhythm Holdings Issues Update On Cybersecurity Incident Previously Disclosed in June 2026; Continues To Believe Incident Not Expected To Have Material Impact On Co's Financial Condition
iRhythm Holdings, Inc. (NASDAQ:IRTC) today provided an update regarding the cybersecurity incident previously disclosed in June 2026. Following completion of the forensic investigation and subsequent…
1 month ago globenewswire.com
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
Following completion of the forensic investigation, company begins notifying impacted individuals Following completion of the forensic investigation, company begins notifying impacted individuals
1 month ago globenewswire.com
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
NEW YORK, Sept. 27, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC)…
1 month ago zacks.com
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.
1 month ago defenseworld.net
Hsbc Holdings PLC Takes Position in iRhythm Technologies $IRTC
Hsbc Holdings PLC acquired a new position in shares of iRhythm Technologies (NASDAQ: IRTC) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission…
1 month ago defenseworld.net
California State Teachers Retirement System Buys 5,204,446 Shares of iRhythm Technologies $IRTC
California State Teachers Retirement System raised its stake in iRhythm Technologies (NASDAQ: IRTC) by 13,944.0% in the undefined quarter, according to the company in its most recent disclosure with…
2 months ago zacks.com
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
2 months ago globenewswire.com
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent…
2 months ago seekingalpha.com
iRhythm: The Algorithmic Margin Inflection Changes The Story
iRhythm Technologies is evolving from a cardiac patch producer to a comprehensive cardiac monitoring platform, leveraging software and workflow integration for a competitive advantage. Q2 2026 marked…
-
2 months ago benzinga.com
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $180 to $168.
2 months ago gurufocus.com
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Aug.
2 months ago prnewswire.com
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
2 months ago zacks.com
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform
IRTC's VitalConnect deal expands its cardiac monitoring reach across ambulatory, inpatient and hospital-to-home care while opening new growth opportunities.
2 months ago zacks.com
Here's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2 months ago defenseworld.net
iRhythm Technologies $IRTC Shares Sold by Bank of America Corp DE
Bank of America Corp DE trimmed its holdings in iRhythm Technologies (NASDAQ: IRTC) by 41.7% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 432,539…
-
2 months ago benzinga.com
Truist Securities Maintains Buy on iRhythm Holdings, Raises Price Target to $168
Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $160 to $168.
2 months ago benzinga.com
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
iRhythm to acquire VitalConnect for $287.5 million, expands cardiac monitoring portfolio after Q2 earnings beat and higher fiscal 2026 guidance.
-
2 months ago benzinga.com
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $168
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $180 to $168.
-
2 months ago benzinga.com
Needham Maintains Buy on iRhythm Holdings, Lowers Price Target to $192
Needham analyst David Saxon maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $255 to $192.
-
2 months ago benzinga.com
Evercore ISI Group Maintains Outperform on iRhythm Holdings, Raises Price Target to $165
Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and raises the price target from $150 to $165.
-
2 months ago benzinga.com
iRhythm To Acquire Maker Of Wearable Biosensor And Ambulatory Cardiac Monitoring Technology Vital Connect For ~$237.5M In Cash And ~$50M In IRTC Stock
Upon closing, the transaction is expected to immediately expand iRhythm's addressable market and advance its evolution into a broader cardiac monitoring and intelligence platform. VitalConnect…
-
2 months ago benzinga.com
iRhythm Holdings Raises FY2026 Sales Guidance from $875.000M-$885.000M to $880.000M-$890.000M vs $881.129M Est
iRhythm Holdings (NASDAQ:IRTC) raises FY2026 sales outlook from $875.000 million-$885.000 million to $880.000 million-$890.000 million vs $881.129 million estimate.
-
2 months ago benzinga.com
iRhythm Technologies Q2 Adj. EPS $0.58 Beats $(0.00) Estimate, Sales $224.172M Beat $219.324M Estimate
iRhythm Technologies (NASDAQ:IRTC) reported quarterly earnings of $0.58 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 281.25 percent increase over…
-
3 months ago benzinga.com
Stephens & Co. Initiates Coverage On iRhythm Holdings with Overweight Rating, Announces Price Target of $160
Stephens & Co. analyst Mason Carrico initiates coverage on iRhythm Holdings (NASDAQ:IRTC) with a Overweight rating and announces Price Target of $160.
-
3 months ago benzinga.com
Truist Securities Maintains Buy on iRhythm Holdings, Lowers Price Target to $160
Truist Securities analyst Richard Newitter maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $174 to $160.
-
4 months ago benzinga.com
Evercore ISI Group Maintains Outperform on iRhythm Holdings, Lowers Price Target to $150
Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers the price target from $160 to $150.
-
4 months ago benzinga.com
BTIG Reiterates Buy on iRhythm Holdings, Maintains $185 Price Target
BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $185 price target.
4 months ago benzinga.com
Top 3 Health Care Stocks You'll Regret Missing In Q2
Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold, according to Benzinga Pro. iRhythm, Procept Biorobotics, Anbio Biotechnology among lowest RSI values.
4 months ago benzinga.com
iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive Data
iRhythm says hackers stole patient and proprietary data from third-party apps but sees no material impact on operations or finances.
-
4 months ago benzinga.com
iRhythm Reports Material Cybersecurity Incident Involving Exfiltration Of Patient And Corporate Data From Third-Party Applications Following Social Engineering Attack
Material Cybersecurity Incidents. On June 8, 2026, iRhythm Holdings, Inc. (the "Company") identified unauthorized activity involving data maintained on certain third-party-hosted business…
-
4 months ago benzinga.com
BTIG Reiterates Buy on iRhythm Holdings, Maintains $185 Price Target
BTIG analyst Marie Thibault reiterates iRhythm Holdings (NASDAQ:IRTC) with a Buy and maintains $185 price target.
-
5 months ago benzinga.com
iRhythm Technologies Settles Class Action Securities Litigation With $45M Payment For Dismissal With Prejudice
On June 3, 2026, iRhythm Technologies, Inc. ("iRhythm Tech"), a wholly owned subsidiary of iRhythm Holdings, Inc. (the "Company"), entered into a binding Stipulation and Agreement of Settlement (the…
-
5 months ago benzinga.com
Canaccord Genuity Maintains Buy on iRhythm Holdings, Lowers Price Target to $152
Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $180 to $152.
-
5 months ago benzinga.com
B of A Securities Maintains Buy on iRhythm Holdings, Lowers Price Target to $180
B of A Securities analyst Stephanie Piazzola maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $225 to $180.
-
6 months ago benzinga.com
Citigroup Maintains Buy on iRhythm Holdings, Raises Price Target to $157
Citigroup analyst Joanne Wuensch maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and raises the price target from $155 to $157.
-
6 months ago benzinga.com
Canaccord Genuity Maintains Buy on iRhythm Holdings, Lowers Price Target to $180
Canaccord Genuity analyst William Plovanic maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $198 to $180.
-
6 months ago benzinga.com
JP Morgan Maintains Overweight on iRhythm Holdings, Lowers Price Target to $175
JP Morgan analyst Allen Gong maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $215 to $175.
-
6 months ago benzinga.com
Wells Fargo Maintains Overweight on iRhythm Holdings, Lowers Price Target to $180
Wells Fargo analyst Nathan Treybeck maintains iRhythm Holdings (NASDAQ:IRTC) with a Overweight and lowers the price target from $200 to $180.
-
6 months ago benzinga.com
Evercore ISI Group Maintains Outperform on iRhythm Holdings, Lowers Price Target to $160
Evercore ISI Group analyst Vijay Kumar maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers the price target from $170 to $160.